Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Germany / NCT00669266
Recruiting Observational

Adrenal Tumors - Pathogenesis and Therapy

NCT00669266 · tracked via the Priya Life Science Germany tracker
Sponsor
University of Wuerzburg
Phase
Observational
Started
2002-09
Last updated
2026-05-07

Condition(s) studied

Adrenal TumorsAdrenocortical CarcinomaCushing SyndromeConn SyndromePheochromocytoma

Study summary

The pathogenesis of adrenal tumors is still not fully elucidated and the treatment options for malignant tumors are poor. The current study investigates different aspects of the pathogenesis of adrenal tumors and evaluates different therapeutic options in patients with adrenocortical carcinoma.

Eligibility

Sex
ALL
Min age
—
Max age
100 Years
Healthy volunteers
No
Inclusion Criteria: * adrenal tumor detected by imaging Exclusion Criteria:

Trial sites (1)

FacilityCityRegionStatus
University of Wuerzburg Würzburg Germany Recruiting

More University of Wuerzburg trials in Germany

Registry for Hypoparathyroidism Wuerzburg Recruiting
Effects of Isolated Lumbar Extension Resistance Training Alone and in Combination with General Exercise and Manual Therapy Active, not recruiting
German Adrenocortical Carcinoma Registry Recruiting
I-124 PET/CT Based Remnant Radioiodine Ablation Decision Concept in Differentiated Thyroid Cancer Active, not recruiting
Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma Active, not recruiting

Other trials for the same condition

Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome Active, not recruiting
German Adrenocortical Carcinoma Registry Recruiting
Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma Active, not recruiting
Evaluation of Side Effects of Mitotane Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT00669266 on ClinicalTrials.gov ↗ ← All trials in Germany